Enjoy complimentary customisation on priority with our Enterprise License!
The veterinary clostridium vaccine market size has the potential to grow by USD 158.58 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.
This report provides a detailed analysis of the market by end-user (swine, bovine, poultry, and others) and geography (APAC, Europe, MEA, North America, and South America). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Bioveta AS, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Covetrus Inc., Elanco, Animal Health Inc., LABORATORIOS HIPRA SA, Merck & Co. Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc.
The veterinary clostridium vaccine market is concentrated. Market vendors are acquiring new facilities to synergize their R&D capability and develop new products for target users. Animal Health Inc., LABORATORIOS HIPRA SA, Merck & Co. Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc. are some of the major market participants. Although the dependency on livestock products will offer immense growth opportunities, manufacturing and storage issues will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this veterinary clostridium vaccine market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this veterinary clostridium vaccine market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading companies, including:
North America was the largest veterinary clostridium vaccine market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. Growing husbandry practices, improved farm management, and technological advances such as growing usage of continuous cell lines as substrates and approval of fermenter technology for clostridium vaccine productions by the USDA will significantly influence veterinary clostridium vaccine market growth in this region.
Almost 44% of the market’s growth will originate from North America during the forecast period. The US is a key market for the veterinary Clostridium vaccine in North America. Market growth in this region will be faster than the growth of the market in MEA and South America.
Swine is the most largely affected animal species by various diseases caused due to clostridial species such as Clostridium perfringens type A, Clostridium perfringens type C, and Clostridium difficile. Hence the demand for veterinary Clostridium vaccine is expected to be high for the treatment of swine during the forecast period.
However, market growth in this segment will be slower than the growth of the market in the poultry segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the veterinary clostridium vaccine market size.
The veterinary clostridium vaccine market will register a CAGR of over 5% during the forecast period. Government initiatives to increase the awareness of vaccinations is one of the key factors that will drive veterinary clostridium vaccine market growth during the forecast period. The National Office of Animal Health in the US is coming up with initiatives to create an awareness program regarding clostridial diseases. They are also taking efforts to develop safer, effective, and quality medicines for the health and welfare of animals. Additionally, the department of agriculture and fisheries in Queensland is also focusing on creating awareness about various clinical manifestations in animals affected by clostridial infections. They are establishing various programs for the safety of food. To prevent animal deaths and the spread of zoonotic disease, these vendors are extensively promoting vaccination for diseases.
The introduction of combination vaccines, one of the key veterinary clostridium vaccine market trends, will also influence market growth. Bovine rotavirus-coronavirus vaccine-clostridium perfringens type C-escherichia coli bacterin toxoid is one of the major combination vaccines approved by the USDA. Vaccines such as porcine rotavirus vaccine-clostridium perfringens type C-escherichia coli bacterin-toxoid are developed with the aim to prevent the prevalence of multiple disease conditions along with clostridial diseases.
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.